
Cathie Wood led Ark Invest on Wednesday initiated a position in Moderna Inc (NASDAQ: MRNA) after the biotech company said an updated version of its COVID-19 booster vaccine appeared to provide stronger protection against the Omicron variant than its current shot.
St. Petersburg, Florida-based Ark Invest bought 172,939 shares, estimated to be worth $25.68 million, in Moderna.